Skip to main content
. 2021 Sep 15;16(9):e0251665. doi: 10.1371/journal.pone.0251665

Fig 3. Adjusted effect estimate of NAFLD/NASH on average daily dose of warfarin using the propensity score stratification approach after the first 2 months of warfarin use.

Fig 3

Note: NAFLD: Nonalcoholic Fatty Liver Disease; NASH: Nonalcoholic Steatohepatitis; ADD: Average Daily Dose.